#Myeloid

Yates Investing

yatesinvesting

$ATNM DD thread: I’m going to leave some links below so you can research for your self as well. https://www.actiniumpharma.com/product-pipeline/iomab-bhttps://www.actiniumpharma.com/product-pipelinehttps://www.actiniumpharma.com/awe-techn

Elizabeth McKenna

ElizSMcKenna

In honor of the Ham-Wasserman Lecture by Andrew Roberts at #ASH20, I'd like to share some of the key #venetoclax content published in @CD_AACR over the past few years: From

Alex Berenson

AlexBerenson

1/ Nothing to see here, Moderna edition: Like the @pfizer vaccine, the @moderna_tx vaccine led to more pregnancy loss in rat studies (the ONLY studies done). Vaccinated rats lost 16%

Francesco Maura

FrancescoMaura4

In 2020 with @DrOlaLandgren we revealed how Melphalan has strong mutagenic activity on myeloma cells. This can understandably create fear for patients who have undergone transplant, and we have received

Catherine Smith, MD

SmithLabSF

Be still my heart, you know I love me some drug resistance talks! Session 604 was! Some highlights. THREAD. #ASH20 #ASHFromHome #ASHtogether #leusm #ImaHemeDork. 1)First up, on target resistance wins

Chris Hourigan

DrChrisHourigan

My thoughts on "A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients" | Blood Advances | American Society of Hematology https://ashpublications.org/bloodadvances

Craig Wilen

WilenLab

Excited to share our new paper led by @chennifer_jen looking at the role of NSAIDs in #COVID19. NSAIDs dampen the cytokine and antibody response to SARS-CoV-2 infection @ASMicrobiology @JVirology @Yale_LabMed

Holly Figueroa O'Reilly

AynRandPaulRyan

1/ My husband has been feeling poorly for a few days and decided to go in to be tested for COVID-19.Instead, we just found out that he has AML: acute

Stephen Schwartz

AtomicAnalyst

Fifty years ago this morning, Baneberry—a 10-kiloton, weapons-related, underground nuclear test 912 feet beneath the Nevada Test Site—accidentally vented, releasing 80,000 curies of radioactive iodine-131, more than any other US

Adrian Liston

LabListon

I am really thrilled to release #AutoSpill onto @biorxivpreprint. It is a novel method for applying compensation to #flowcytometry data, which reduces the error by ~100,000-fold. It is thanks to

Mike Thompson, MD, PhD, FASCO

mtmdphd

[THREAD] #ClinicalTrials Eligibility [Updated Mar 11, 2020] #ctsm Modernizing Eligibility Criteria for Molecularly Driven #ClinicalTrials [7/20/15] - @EdKimMDLCI et al. JCO @ASCO_pubs http://ow.ly/RGEdG metRCC Clinical Trial Participa

irony of life

InvestorSwan

$cris Press release oncology care - A mini threadcc: @oncology_bg @VPrasadMDMPH 1. Curis released its preliminary data on CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and

Bishal Gyawali

oncology_bg

This thread is going to be a collection of all my #globaloncology papers, primarily for my own reference to bookmark for quick access but also, just in case, it is

Ambulatus

ambulatus

$RAC.AX #asx #oncology #cancer@RaceOncology could be a 2021 #asx 10+ baggerWhy follows in this thread. First watch the strategy video./1https://www.youtube.com/watch?v=J7WKOtMEPnI Bisantrene was shown decades ago to be safe and effective

Shelly Asquith

ShellyAsquith

It's #WorldCancerDay Last year 18,000 people were diagnosed with a type of cancer caused by their job. Sadly 9,000 people died from occupational cancer.Asbestos is still the biggest cause of

Hiro Proto

proto_hiro

1. It’s hard to oversell the promise of CRISPR. It’s one of the most fundamental discoveries of the 21st century. It essentially leverages an infection-fighting mechanism in bacteria to edit

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.